Lectin from Agrocybe aegerita as a Glycophenotype Probe for Evaluation of Progression and Survival in Colorectal Cancer |
Liang, Yi
(Department of Clinical Immunology, Guangdong Medical College)
Chen, Hua (Sino-American Cancer Research Institute, Guangdong Medical College) Zhang, Han-Bin (Sino-American Cancer Research Institute, Guangdong Medical College) Jin, Yan-Xia (The College of Life Sciences, Wuhan University) Guo, Hong-Qiang (The Affiliated Cancer Hospital of Zhengzhou University) Chen, Xing-Gui (Cancer Center, the Affiliated Hospital of Guangdong Medical College) Sun, Hui (The College of Life Sciences, Wuhan University) |
1 | Baldus SE, Zirbes TK, Hanisch FG, et al (2000) Thomsen-Friedenreich antigen presents as a prognostic factor incolorectal carcinoma: A clinicopathologic study of 264patients. Cancer, 88, 1536-43. DOI |
2 | Adamczyk B, Tharmalingam T, Rudd PM (2011). Glycans as cancer biomarkers. Biochim Biophys Acta, 1820, 1347-53. |
3 | Allen HJ, Ahmed H, Matta KL (1998). Binding of synthetic sulfated ligands by human splenic galectin 1, a betagalactoside-binding lectin. Glycoconj J, 15, 691-5. DOI |
4 | Balog CI, Stavenhagen K, Fung WL, et al (2012). N-glycosylation of colorectal cancer tissues: a liquid chromatographyand mass spectrometry-based investigation. Mol Cell Proteomics, 11, 571-85. DOI |
5 | Itzkowitz SH, Yuan M, Montgomery CK, et al (1989). Expressionof Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res, 49, 197-204. |
6 | Liang Y, Feng L, Tong X, et al (2009). Importance of nuclear localization for the apoptosis-induced activity of a fungal galectin AAL (Agrocybe aegerita lectin). Biochem BiophysRes Commun, 386, 437-42. DOI |
7 | Meany DL, Chan DW (2011). Aberrant glycosylation associatedwith enzymes as cancer biomarkers. Clin Proteomics, 8, 7. DOI |
8 | Qiu Y, Patwa TH, Xu L, et al (2008). Plasma glycoproteinprofiling for colorectal cancer biomarker identificationby lectin glycoarray and lectin blot. J Proteome Res, 7,1693-703. DOI |
9 | Reis CA, Osorio H, Silva L, et al (2010). Alterations inglycosylation as biomarkers for cancer detection. J Clin Pathol, 63, 322-9. DOI ScienceOn |
10 | Schneider F, Kemmner W, Haensch W, et al (2001). Overexpressionof sialyltransferase CMP-sialic acid:Galbeta1, 3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res, 61, 4605-11. |
11 | Sethi MK, Thaysen-Andersen M, Smith JT, et al (2013). Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and alpha-2,3-linkedsialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines. J Proteome Res, 13, 277-88. |
12 | Storr SJ, Royle L, Chapman CJ, et al (2008). The O-linkedglycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Glycobiology, 18, 456-62. DOI |
13 | Szajda SD, Jankowska A, Zwierz K (2008). Carbohydratemarkers in colon carcinoma. Dis Markers, 25, 233-42. DOI |
14 | Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer incidence and mortality Worldwide: IARC Cancer Base, No. 11. |
15 | Chandrasekaran EV, Xue J, Neelamegham S, Matta KL (2006). The pattern of glycosyl- and sulfotransferase activitiesin cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Carbohydr Res, 341,983-94. DOI |
16 | Essentials of Glycobiology (2009). Cold Spring HarborLaboratory Press, Cold Spring Harbor (NY). |
17 | Feng L, Sun H, Zhang Y, et al (2010). Structural insights into the recognition mechanism between an antitumor galectin AA Land the Thomsen-Friedenreich antigen. FASEB J, 24, 3861-8. DOI |
18 | Gunderson LL, Jessup JM, Sargent DJ, et al (2010). Revised TNcategorization for colon cancer based on national survival outcomes data. J Clin Oncol, 28, 264-71. DOI ScienceOn |
19 | Huang GL, Guo HQ, Yang F, et al (2012) Activating transcriptionfactor 1 is a prognostic marker of colorectal cancer. Asian Pac J Cancer Prev, 13, 1053-7. DOI |
20 | Ideo H, Seko A, Ohkura T, et al (2002). High-affinity binding of recombinant human galectin-4 to SO(3)(-)-->3Galbeta1->3GalNAc pyranoside. Glycobiology, 12, 199-208. DOI ScienceOn |
21 | Ideo H, Seko A, Yamashita K (2005). Galectin-4 binds to sulfatedglycosphingolipids and carcinoembryonic antigen in patcheson the cell surface of human colon adenocarcinoma cells. J Biol Chem, 280, 4730-7. DOI |
22 | Indramanee S, Silsirivanit A, Pairojkul C, et al (2012). Aberrant glycosylation in cholangiocarcinoma demonstrated by lectinhistochemistry. Asian Pac J Cancer Prev, 13, 119-24. |
23 | Rambaruth ND, Greenwell P, Dwek MV (2012). The lectinHelix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer. Glycobiology, 22,839-48. DOI |
24 | Yehezkel G, Cohen L, Kliger A, et al (2012). O-linked beta-Nacetylglucosaminylation (O-GlcNAcylation) in primary andmetastatic colorectal cancer clones and effect of N-acetylbeta-D-glucosaminidase silencing on cell phenotype andtranscriptome. J Biol Chem, 287, 28755-69. DOI |
25 | Zhao C, Sun H, Tong X, Qi Y (2003). An antitumour lectinfrom the edible mushroom Agrocybe aegerita. Biochem J,374, 321-7. DOI ScienceOn |